TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
Go back to TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 218.50 -3 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.50 | 52 Week High | $333.65 | |||
| Open | $221.17 | 52 Week Low | $223.02 | |||
| Day High | $222.00 | P/E | 27.98 | |||
| Day Low | $216.78 | EPS | $7.81 | |||
| Volume | 517,485 | |||||
